Skip to main content
Molecular Neurodegeneration logoLink to Molecular Neurodegeneration
. 2016 Feb 23;11:20. doi: 10.1186/s13024-016-0086-3

Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Wendy E Heywood 1,5, Daniela Galimberti 2, Emily Bliss 1, Ernestas Sirka 1, Ross W Paterson 3, Nadia K Magdalinou 4, Miryam Carecchio 5, Emma Reid 1, Amanda Heslegrave 3, Chiara Fenoglio 2, Elio Scarpini 2, Jonathan M Schott 3, Nick C Fox 3, John Hardy 3, Kailash P Bhatia 3, Simon Heales 1,6, Neil J Sebire 6, Henrik Zetterberg 3,7, Kevin Mills 1,6,
PMCID: PMC4763435  PMID: 26907468

After publication of this work [1], we noted that the names of two authors Kailash Bhatia and Henrik Zetterberg had been misspelled. The names have now been corrected above.

Footnotes

Wendy E. Heywood and Daniela Galimberti as joint first author.

Henrik Zetterberg and Kevin Mills as joint last author.

The online version of the original article can be found under doi:10.1186/s13024-015-0059-y.

Reference

  • 1.Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, et al. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener. 2015;10:64. doi: 10.1186/s13024-015-0059-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Neurodegeneration are provided here courtesy of BMC

RESOURCES